Dapayan Tablet
Marketer
Nirosha Lifesciences
Salt Composition
Dapagliflozin (10mg)
Overview Dapayan Tablet
Glyciphage tablets are indicated for managing type 2 diabetes, either independently or as part of a multi-drug regimen. Their action centers on regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and promoting cardiovascular health. Glyciphage may be ingested with or without food, but consistent daily timing is recommended; dosage is determined by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can lead to hyperglycemia and potentially serious consequences such as renal impairment and vision loss. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Common adverse effects include vaginal candidiasis, upper respiratory tract inflammation, and urinary tract infections. The medication can induce diuresis; increased fluid intake is crucial to prevent dehydration. Practicing good hygiene helps reduce the likelihood of genital fungal infections. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use with your physician. Pregnant or lactating individuals should seek medical counsel before using this medication. Limiting alcohol consumption is advised, as it may heighten the probability of adverse reactions. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapayan Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Dapayan Tablet
Managing type 2 diabetes
Major Benefits of Dapayan Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapayan Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dapayan Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapayan Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapayan Tablets can be consumed with or without food, though consistent timing is recommended.
How Dapayan Tablet works:
Dapayan tablets help manage blood sugar levels. Their mechanism involves facilitating the excretion of excess glucose via urine.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Dapayan Tablets.
PregnancyCONSULT YOUR DOCTOR
Using Dapayan Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapayan Tablet while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Individuals with kidney disorders should likely refrain from using Dapayan Tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapayan tablets pose no safety concerns for individuals with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dapayan Tablet :
Should you forget a Dapayan Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapayan Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



